Endotoxin in Gram-negative Septic Shock
NCT01602354 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2012-06-28
Summary
The purpose of this observational study is to determine whether endotoxin levels and/or their trends can be considered predictive of morbility or mortality in septic shock caused by gram-negative bacteria, searching also for a possible correlation with Simplified Acute Physiology Score (SAPS II), Sequential Organ Failure Assessment (SOFA), White Blood Cells (WBC) and Platelets (PLT).
Conditions
- Gram Negative Septic Shock
Sponsors & Collaborators
-
Azienda Ospedaliero, Universitaria Pisana
lead OTHER
Principal Investigators
-
Francesco Forfori, Researcher · Department of Intensive Care Unit, Azienda Ospedaliero-Universitaria (AOU) Pisana
-
Francesco Giunta, Professor · Depatment of Intensive Care Unit, AOU Pisana
-
Imma Tatiana Borrelli, Doctor · Department of Intensive Care Unit, AOU Pisana
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-06-30
- Completion
- 2013-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis
NCT00629382 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Role of Thromboelastography in Septic Shock
NCT03095625 ·Status: COMPLETED
-
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis
NCT05787184 ·Status: UNKNOWN
-
Physiologic Indicators for Prognosis in Abdominal Sepsis Study
NCT03408600 ·Status: COMPLETED
-
Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.
NCT02300415 ·Status: UNKNOWN
-
Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190 ·Status: UNKNOWN
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
The PvCO2-PaCO2/CaO2-CvO2 Ratio in Septic Shock
NCT07096284 ·Status: RECRUITING
-
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock
NCT00159952 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nasal and Gut Microbiota Combined Clinical Events Predicts the Prognosis of Septic Patients
NCT05143736 ·Status: RECRUITING
-
Focused Ultrasound in Septic Shock Patients
NCT01920776 ·Status: UNKNOWN ·Phase: NA
-
Role of Early Point of Care Ultrasound in Management of Sepsis in Emergency Department
NCT05849194 ·Status: COMPLETED ·Phase: NA
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
The Relation Between Triglyceride- Glucose Index, Procalcitonin and Cardiac Affection in Septic Shock.
NCT06518083 ·Status: NOT_YET_RECRUITING
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock
NCT02730624 ·Status: COMPLETED ·Phase: PHASE4
-
Short-course Antimicrobial Therapy in Sepsis
NCT02899143 ·Status: UNKNOWN ·Phase: PHASE2
-
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 ·Status: UNKNOWN ·Phase: NA
-
VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 ·Status: COMPLETED
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
NCT06548854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection
NCT01025180 ·Status: TERMINATED ·Phase: PHASE4
-
(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis
NCT02734550 ·Status: COMPLETED ·Phase: NA
-
A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis
NCT07089524 ·Status: RECRUITING